🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
31/08/1981 0,0172 USD
01/06/1981 0,0172 USD
02/03/1981 0,0172 USD
02/12/1980 0,0172 USD
29/08/1980 0,0152 USD
02/06/1980 0,0152 USD
28/02/1980 0,0152 USD
03/12/1979 0,0152 USD
31/08/1979 0,0126 USD
25/05/1979 0,0126 USD
01/03/1979 0,0126 USD
04/12/1978 0,0126 USD
28/08/1978 0,0113 USD
26/05/1978 0,0113 USD
02/03/1978 0,0113 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/01/1994 17,59 17,77 17,35 17,71 +1,36% 2,37% 7.269.766
06/01/1994 17,83 17,89 17,41 17,47 -1,68% 2,68% 8.273.331
05/01/1994 17,24 18,13 17,18 17,77 +3,47% 5,54% 23.320.096
04/01/1994 17,00 17,24 16,88 17,18 +2,13% 2,11% 7.748.493
03/01/1994 16,58 16,94 16,52 16,82 +2,55% 2,52% 7.951.176
31/12/1993 16,52 16,58 16,40 16,40 -1,08% 1,08% 4.289.883
30/12/1993 16,70 16,76 16,58 16,58 -1,07% 1,07% 4.078.397
29/12/1993 16,94 17,00 16,58 16,76 -0,35% 2,47% 6.414.389
28/12/1993 16,76 17,00 16,70 16,82 +0,00% 1,78% 7.594.437
27/12/1993 16,52 16,82 16,46 16,82 +2,92% 2,17% 7.718.101
23/12/1993 16,40 16,64 16,28 16,34 +0,37% 2,18% 6.404.538
22/12/1993 16,34 16,40 16,10 16,28 +0,37% 1,82% 6.177.541
21/12/1993 16,22 16,34 16,16 16,22 +0,37% 1,10% 5.543.920
20/12/1993 16,16 16,28 16,04 16,16 +0,74% 1,48% 6.921.621
17/12/1993 15,86 16,16 15,80 16,04 +1,51% 2,26% 9.835.061
16/12/1993 15,80 15,86 15,68 15,80 +0,76% 1,13% 5.980.517
15/12/1993 15,63 15,86 15,57 15,68 +0,77% 1,91% 7.509.549
14/12/1993 15,68 15,68 15,57 15,57 -0,76% 0,76% 4.428.219
13/12/1993 15,74 15,86 15,57 15,68 -0,38% 1,89% 5.686.867
10/12/1993 15,74 15,80 15,45 15,74 -0,38% 2,27% 9.446.882
09/12/1993 16,16 16,16 15,74 15,80 -1,85% 2,58% 6.668.005
08/12/1993 16,22 16,28 16,04 16,10 -1,10% 1,47% 3.482.714
07/12/1993 16,34 16,40 16,22 16,28 -0,36% 1,09% 4.723.965
06/12/1993 16,34 16,46 16,22 16,34 +0,73% 1,46% 7.643.693
03/12/1993 16,10 16,22 15,98 16,22 +1,12% 1,48% 7.514.789
02/12/1993 16,22 16,28 16,04 16,04 -1,10% 1,47% 6.175.445
01/12/1993 16,40 16,40 16,22 16,22 -0,73% 1,09% 8.505.778
30/11/1993 16,16 16,34 16,04 16,34 +1,11% 1,84% 7.599.467
29/11/1993 16,58 16,58 16,16 16,16 -1,81% 2,52% 6.046.331
26/11/1993 16,58 16,58 16,46 16,46 +0,00% 0,72% 1.721.864